Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H21NO |
| Molecular Weight | 267.3654 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(C1CCNCC1)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=ZMISODWVFHHWNR-UHFFFAOYSA-N
InChI=1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2
| Molecular Formula | C18H21NO |
| Molecular Weight | 267.3654 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Azacyclonol (aka gamma-pipradrol) is an ataractive agent; a compound which diminished hallucinations in psychotic individuals. It is sometimes referred to as a tranquilizer or antipsychotic, though it does not actually possess these properties. It was used in Europe during the 1950's for treatment of schizophrenia; likely to reduce the psychedelic effects of LSD and mescaline. However, it had mixed clinical effectiveness and did not gain widespread adoption and was eventually discontinued. Azacyclonol was sold under several trade names: Ataractan, Calmeran, Frenoton, Frenquel and Psychosan.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes. | 2006-08 |
|
| The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. | 2006-03 |
|
| The effect of rifampin administration on the disposition of fexofenadine. | 2001-03 |
|
| Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. | 1999-05 |
|
| THE HYPOGLYCAEMIC EFFECT OF AZACYCLONOL AND ITS MECHANISM. | 1963-10-01 |
|
| [Azacyclonol (Frenquel). Uses and results]. | 1960-10 |
|
| Azacyclonol in chronic schizophrenia. | 1959-09-01 |
|
| Intravenous use of azacyclonol. | 1958-05 |
|
| Azacyclonol (frenquel) hydrochloride in the treatment of chronic schizophrenia; a double-blind, controlled study. | 1957-09-28 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13383414
Chronic Schizophrenics were treated for four weeks with daily oral doses of 20 mg Frenquel to control the hallucinogenic effects of LSD. Twenty-one of thirty-eight patients showed definite improvements, while seven more showed doubtful-improvement. Frenquel was also used in oral doses of up to 400 mg daily.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:47:44 GMT 2025
by
admin
on
Mon Mar 31 17:47:44 GMT 2025
|
| Record UNII |
2MMR990PEM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2MMR990PEM
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
m575
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | Merck Index | ||
|
3680
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
100000086907
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
115-46-8
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
655
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
DTXSID2045280
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
SUB05628MIG
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
15723
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
C100095
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
AZACYCLONOL
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
204-092-5
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
CHEMBL127508
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY | |||
|
C76502
Created by
admin on Mon Mar 31 17:47:44 GMT 2025 , Edited by admin on Mon Mar 31 17:47:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
MAJOR
URINE
|
||
|
PARENT -> METABOLITE INACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|